Abstract
Children with chronic kidney disease (CKD) are at high risk of developing mineral and bone disorders (MBD). CKD-MBD comprise altered calcium and phosphate homeostasis, abnormal synthesis and secretion of parathyroid hormone (PTH) and vitamin D and alterations in bone metabolism and function. The growing skeleton is particularly vulnerable; optimal control of bone and mineral homeostasis is essential to prevent debilitating skeletal complications, achieve adequate growth and preserve long-term cardiovascular health. Optimal control of bone and mineral metabolism remains one of the major challenges in the treatment of paediatric patients with CKD.
This chapter discusses CKD-MBD problems at different ages and stages of CKD. Currently used biochemical and radiological diagnostic tools are presented, and therapeutic algorithms based on recent paediatric guidelines are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bacchetta J, Harambat J, Cochat P, Salusky IB, Wesseling-Perry K. The consequences of chronic kidney disease on bone metabolism and growth in children. Nephrol Dial Transplant. 2012;27(8):3063–71.
Wesseling-Perry K, Salusky IB. Phosphate binders, vitamin D and calcimimetics in the management of chronic kidney disease-mineral bone disorders (CKD-MBD) in children. Pediatr Nephrol. 2013;28(4):617–25.
Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, et al. Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol. 2010;5(10):1860–6.
Shroff R, Long DA, Shanahan C. Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol. 2013;24(2):179–89.
Groothoff JW, Offringa M, Van Eck-Smit BL, Gruppen MP, Van De Kar NJ, Wolff ED, et al. Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int. 2003;63(1):266–75.
Borzych D, Rees L, Ha IS, Chua A, Valles PG, Lipka M, et al. The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010;78(12):1295–304.
Denburg MR, Tsampalieros AK, de Boer IH, Shults J, Kalkwarf HJ, Zemel BS, Foerster D, Stokes D, Leonard MB. Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab. 2013;98:1930–8.
Denburg MR, Kumar J, Jemielita T, Brooks ER, Skversky A, Portale AA, Salusky IB, Warady BA, Furth SL, Leonard MB. Fracture burden and risk factors in childhood CKD: results from the CKiD Cohort Study. J Am Soc Nephrol. 2016;27:543–50.
Ketteler M, Elder GJ, Evenepoel P, Ix JH, Jamal SA, Lafage-Proust MH, et al. Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney disease: improving global outcomes controversies conference. Kidney Int. 2015;87(3):502–28.
Rees L, Shroff R. The demise of calcium-based phosphate binders-is this appropriate for children? Pediatr Nephrol. 2015;30:2061–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Shroff, R. (2017). Chronic Kidney Disease – Mineral and Bone Disorder. In: Warady, B., Schaefer, F., Alexander, S. (eds) Pediatric Dialysis Case Studies. Springer, Cham. https://doi.org/10.1007/978-3-319-55147-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-55147-0_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-55145-6
Online ISBN: 978-3-319-55147-0
eBook Packages: MedicineMedicine (R0)